The carbon footprint of different medication packaging items at an Australian tertiary hospital
Open Access
- 2 October 2025
- journal article
- Published by Wiley in Journal of Pharmacy Practice and Research
- Vol. 56 (2) , 147-155
Abstract
Background: Medication packaging contributes significantly to the overall carbon footprint of pharmaceuticals. Packaging design and material choices greatly influence environmental impact. Aim: To assess the carbon footprint of packaging for a range of medications on an Australian tertiary hospital formulary and identify opportunities to reduce environmental impact. Method: A life cycle assessment was undertaken to calculate the carbon footprint (as CO 2 equivalent, [CO 2 e]) of medication packaging across six common product categories: blisters, tablets in bottles, oral liquids in bottles, vials, glass ampoules, and plastic ampoules. Ethical approval was granted by the Alfred Health Ethics Committee (Reference no: 465/23) and the study conforms with the National Health and Medical Research Council Ethical considerations in quality assistance and evaluation activities . Results: Twenty‐six products were assessed across the six categories. Within each category, the CO 2 e of the lowest footprint products was between 19% (for glass ampoules) and 76% (for blisters) lower than the highest footprint products. Differences in carbon footprint were mostly due to the use of alternative materials or from smaller packaging (e.g. from less empty space). Recycling aluminium from blisters, or the glass or plastic comprising tablet bottles, also improved the environmental performance of those products, with CO 2 e reductions of up to 81% and 56%, respectively. Some safety features (e.g. printing information over every blister‐packed tablet) may conflict with sustainability principles (avoiding empty space). Conclusion: The environmental impact of packaging can be reduced by using materials with a lower footprint, decreasing packaging size and weight, and/or promoting greater recycling of waste materials. Some safety features promote larger packaging and increased use of raw materials, but this is not universally the case.Keywords
This publication has 19 references indexed in Scilit:
- Environmental considerations along the life cycle of pharmaceuticals: Interview study on views regarding environmental challenges, concerns, strategies, and prospects within the pharmaceutical industryEuropean Journal of Pharmaceutical Sciences, 2024
- Life cycle assessment of pharmaceutical packaging addressing end-of-life alternativesWaste Management, 2023
- The 2023 report of the Lancet Countdown on health and climate change: the imperative for a health-centred response in a world facing irreversible harmsThe Lancet, 2023
- Life cycle assessment of pharmaceutical packagingThe International Journal of Life Cycle Assessment, 2022
- Ecodesign approach for pharmaceutical packaging based on Life Cycle AssessmentScience of The Total Environment, 2022
- The Extent of Medication-Related Hospital Admissions in Australia: A Review from 1988 to 2021Drug Safety, 2022
- Environmental footprint of regular and intensive inpatient care in a large US hospitalThe International Journal of Life Cycle Assessment, 2021
- Comparing the environmental impacts of paracetamol dosage forms using life cycle assessmentEnvironment, Development and Sustainability, 2021
- Assessing the sustainability of a manufacturing process using life cycle assessment technique—a case of an Indian pharmaceutical companyClean Technologies and Environmental Policy, 2020
- The ecoinvent database version 3 (part I): overview and methodologyThe International Journal of Life Cycle Assessment, 2016